PPARGC1A and diabetic kidney disease: Similarly, DMY could also mediate the AMPK-PGC-1α-SIRT3 signaling pathway to improve skeletal muscle insulin sensitivity and promote autophagy by activating the AMPK/mTOR signaling pathway, which can alleviate diabetic kidney injury and even retard the progression of diabetic nephropathy.